Search research articles
Contact Us
Filters
Showing results (31-40 of 145) with videos related to
Page
of 15
Sort By:
Expert Opinion on Investigational Drugs
|
July 27, 2017
Therapeutic potential of investigational CHK-1 inhibitors for the treatment of solid tumors
Hani M Babiker, Ali McBride, Laurence S Cooke, et al.
Journal of the Advanced Practitioner in Oncology
|
February 19, 2021
Perceptions of Health-Care Workers of the Cost and Safety of Oral Oncolytic Agents for Patients: A Survey
Madeline Tompkinson, Kelly Fine, Dean Gruber, et al.
The Oncologist
|
May 18, 2018
Global Acceptance of Biosimilars: Importance of Regulatory Consistency, Education, and Trust
Eduardo Cazap, Ira Jacobs, Ali McBride, et al.
JCO Oncology Practice
|
May 7, 2021
Economic Analysis on Adoption of Biosimilar Granulocyte Colony-Stimulating Factors in Patients With Nonmyeloid Cancer at Risk of Febrile Neutropenia Within the Oncology Care Model Framework
Weijia Wang, Edward Li, Kim Campbell, et al.
Journal of Medical Economics
|
December 7, 2016
Economic evaluation for the US of nab-paclitaxel plus gemcitabine versus FOLFIRINOX versus gemcitabine in the treatment of metastatic pancreas cancer
Mahdi Gharaibeh, Ali McBride, J Lyle Bootman, et al.
Journal of the Advanced Practitioner in Oncology
|
June 27, 2022
Practical Strategies for Advanced Practitioners Streamlining the Integration of Oncology Biosimilar Therapies Into Practice
Kelley D Mayden, John M Kelton, Joanne C Ryan, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists
|
March 9, 2016
Ibrutinib for treatment of chronic lymphocytic leukemia
Cory M Vela, Ali McBride, Samantha M Jaglowski, et al.
Journal of the Advanced Practitioner in Oncology
|
November 21, 2017
Biosimilars: Beginning a Conversation
Christopher J Campen, Kelley D Mayden, Ali McBride, et al.
Critical Reviews in Oncology/Hematology
|
April 22, 2017
Potential application and prevalence of the CD30 (Ki-1) antigen among solid tumors: A focus review of the literature
Garrett K Berger, Kevin Gee, Cassandra Votruba, et al.
Hospital Pharmacy
|
September 14, 2018
Pharmacy Operationalization of the Intralesional Oncolytic Immunotherapy Talimogene Laherparepvec
Ali McBride, John Valgus, Sandeep Parsad, et al.
Page
of 15
Search research articles
Search
Showing results (31-40 of 145) with videos related to
Sort By:
Page
of 15
Expert Opinion on Investigational Drugs
|
July 27, 2017
Therapeutic potential of investigational CHK-1 inhibitors for the treatment of solid tumors
Hani M Babiker, Ali McBride, Laurence S Cooke, et al.
Journal of the Advanced Practitioner in Oncology
|
February 19, 2021
Perceptions of Health-Care Workers of the Cost and Safety of Oral Oncolytic Agents for Patients: A Survey
Madeline Tompkinson, Kelly Fine, Dean Gruber, et al.
The Oncologist
|
May 18, 2018
Global Acceptance of Biosimilars: Importance of Regulatory Consistency, Education, and Trust
Eduardo Cazap, Ira Jacobs, Ali McBride, et al.
JCO Oncology Practice
|
May 7, 2021
Economic Analysis on Adoption of Biosimilar Granulocyte Colony-Stimulating Factors in Patients With Nonmyeloid Cancer at Risk of Febrile Neutropenia Within the Oncology Care Model Framework
Weijia Wang, Edward Li, Kim Campbell, et al.
Journal of Medical Economics
|
December 7, 2016
Economic evaluation for the US of nab-paclitaxel plus gemcitabine versus FOLFIRINOX versus gemcitabine in the treatment of metastatic pancreas cancer
Mahdi Gharaibeh, Ali McBride, J Lyle Bootman, et al.
Journal of the Advanced Practitioner in Oncology
|
June 27, 2022
Practical Strategies for Advanced Practitioners Streamlining the Integration of Oncology Biosimilar Therapies Into Practice
Kelley D Mayden, John M Kelton, Joanne C Ryan, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists
|
March 9, 2016
Ibrutinib for treatment of chronic lymphocytic leukemia
Cory M Vela, Ali McBride, Samantha M Jaglowski, et al.
Journal of the Advanced Practitioner in Oncology
|
November 21, 2017
Biosimilars: Beginning a Conversation
Christopher J Campen, Kelley D Mayden, Ali McBride, et al.
Critical Reviews in Oncology/Hematology
|
April 22, 2017
Potential application and prevalence of the CD30 (Ki-1) antigen among solid tumors: A focus review of the literature
Garrett K Berger, Kevin Gee, Cassandra Votruba, et al.
Hospital Pharmacy
|
September 14, 2018
Pharmacy Operationalization of the Intralesional Oncolytic Immunotherapy Talimogene Laherparepvec
Ali McBride, John Valgus, Sandeep Parsad, et al.
Page
of 15